Apotex is a Canadian pharmaceutical corporation. Founded in 1974 by Dr. Bernard Sherman, the company is the largest producer of generic drugs in Canada, with sales exceeding $2 billion (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4,000 dosages, and has 500 molecules under development. Apotex exports products to over 115 countries around the globe. There are more prescriptions filled with Apotex products in Canada than that of any other pharmaceutical company, close to 90 million per year.
Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure.
Apotex is a member of The Canadian Generic Pharmaceutical Association (CGPA), the Generic Pharmaceutical Association (GPhA), an associate member of the Canadian Animal Health Institute (CAHI), the Canadian Association for Pharmacy Distribution Management (CAPDM), as well as the Greater Toronto Area's Partners in Project Green.